Officer sold
~$384KReported value · 14K sh @ $28.37
Roivant Sciences's Chief Accounting Officer sold $384K of Roivant Sciences shares. Nobody planned it ahead of time.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
CEO exercised or converted 200K ROIV derivative securities
Traded Mar 17, 2026 · Filed Mar 20, 2026
- 200K
- Shares · @ $3.85
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 17, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 20, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001635088-26-000026